feed,title,long_url,short_url
Benzinga,"Ventyx Biosciences Chief Scientific Officer Acquires 10,000 Shares After Exercising Company Stock Options",https://benzinga.com/node/35110985,https://da.gd/ZEDeB
Benzinga,Chief Business Officer at Ventyx Biosciences Exercises Options Worth $424K,https://benzinga.com/news/23/10/35110978/chief-business-officer-at-ventyx-biosciences-exercises-options-worth-424k,https://da.gd/GxUGO
Benzinga,P/E Ratio Insights for Unilever,https://benzinga.com/news/23/10/35110979/pe-ratio-insights-for-unilever,https://da.gd/y8BiG
Benzinga,"Akero Therapeutics President and CEO Acquires 25,000 Shares After Exercising Company Stock Options",https://benzinga.com/news/23/10/35110971/akero-therapeutics-president-and-ceo-acquires-25-000-shares-after-exercising-company-stock-options,https://da.gd/JXd5Q
